Profile and Organization
Names | Figures | Facts
Bayer is a global enterprise with core competencies in the fields of health care, nutrition
and high-tech materials. Our products and services are designed to benefit people and improve their
quality of life. At the same time we want to create value through innovation, growth and high
earning power.
The Group is committed to the principles of sustainable development and to its role as a
socially and ethically responsible corporate citizen. Economy, ecology and social responsibility
are corporate policy objectives of equal rank. In fiscal 2012, Bayer employed 111,500 people and
had sales of €39.8 billion. Capital expenditures amounted to €2 billion, R&D expenses to €3
billion.
Organization
Bayer AG defines common values, goals and strategies for the entire Group. The three subgroups and three service companies operate independently, led by the management holding company. The Corporate Center supports the Group Management Board in its task of strategic leadership.
Business operations are the responsibility of the subgroups:
- Bayer HealthCare is among the world’s foremost innovators in the field of pharmaceutical and medical products.
- Bayer CropScience is with its highly effective products, pioneering innovations and keen customer focus, holds global leadership positions in crop protection and non-agricultural pest control.
- Bayer MaterialScience is a renowned supplier of high-performance materials such as polycarbonates and polyurethanes, and innovative system solutions for a wide range of everyday uses.
Central service functions are combined into three service companies:
- Bayer Business Services is the Bayer Group’s international competence center for it-based services.
- Bayer Technology Services is the global technological backbone for the Bayer Group and a major innovation driver.
- Currenta offers services for the chemical industry including utility supply, waste management, infrastructure, safety, security, analytics and vocational training.
Corporate Governance
Dual governance system with the following governance bodies:
| Board of Management: | 4 members, Chairman: Dr. Marijn E. Dekkers |
|---|---|
| Supervisory Board: | 20 members, Chairman: Dr. Manfred Schneider |
Products
The Bayer Group markets some 5,000 products. Best-sellers include:
- in the health care field: Yasmin®/YAZ®/Yasminelle®, Betaferon®/Betaseron®, Kogenate®, Adalat®, Avalox®/Avelox®
- in the nutrition field: Confidor®/ Gaucho®/Admire®/Merit®, Flint®/Stratego®/Sphere®
- in the field of high-tech materials: Makrolon®, Baydur®, Bayflex® Footwear, Desmodur®/Desmophen®
Locations
Bayer is represented around the world by 283* companies. Global headquarters are in Leverkusen, Germany.
* fully consolidated subsidiaries (as of Dec. 31, 2011)
Workforce
52,300 in
Europe
15,300
in North America
26,700
in Asia/Pacific
16,200 in Latin
America/Africa/Middle East
Bayer Stock
- included in nearly all the major share indices
- traded on all German stock exchanges
- dividend per share: EUR 1.90
Bayer Group Key Data
| Bayer-koncernen | 2011
€ million |
2012
€ million |
Change
% |
||
| Net sales | 36,528 | 39,760 | +8.8 | ||
| EBIT | 4,149 | 3,960 | -4.6 | ||
| EBIT before special items | 5,025 | 5,671 | +12.9 | ||
| EBITDA | 6,918 | 6,920 | 0.0 | ||
| EBITDA before special items | 7,613 | 8,284 | +8.8 | ||
| Income before income taxes | 3,363 | 3,248 | -3.4 | ||
| Net income | 2,470 | 2,446 | -1.0 | ||
| Earnings per share (in €) | 2.99 | 2.96 | -1.0 | ||
| Gross cash flow | 5,172 | 4,599 | -11.1 | ||
| Netto cash flow | 5,060 | 4,532 | -10.4 | ||
| Capital expenditures | 1,666 | 2,012 | +20.8 | ||
| Research and development expenses | 2,932 | 3,013 | +2.8 | ||
| Dividend per Bayer AG share (€) | 1.65 | 1.90 | +15.2 |

Jobs & Career ![??? ImageLink[1]/TitleImage ???](/ebbsc/export/sites/nor_internet/da/_galleries/images/Teaserbutton_BAG_150YoB_skyscraper_144x200.png)
